Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 5:34 PM View:  | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 14-Nov-24 | Option Exercise | 2,500 | $2.94 | $7,350.00 | 103% 2.43K to 4.93K | |
| 15-Nov-24 5:34 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 14-Nov-24 | Option Sale | 2,500 | $47.10 | $117,752.00 | (51%) 4.93K to 2.43K | |
| 14-Nov-24 4:34 PM View: | Bjerkholt Eric Chief Financial Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Nov-24 | Grant | 475 | $21.05 | $9,996.85 | 1% 32.8K to 33.28K | |
| 14-Nov-24 4:37 PM View: | Quan Joanne CHIEF MEDICAL OFFICER | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Nov-24 | Grant | 118 | $21.05 | $2,483.43 | 100% 0 to 0.12K | |
| 14-Nov-24 4:32 PM View: | Peetz Christopher CHIEF EXECUTIVE OFFICER Director | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Nov-24 | Grant | 65 | $21.05 | $1,367.99 | < 1% 335.35K to 335.42K | |
| 01-Oct-24 4:39 PM View: | Grey Michael G Director | Mirum Pharmaceuticals, Inc. (MIRM) | 27-Sep-24 | Gift | 102,788 | -- | -- | (27%) 382.95K to 280.16K | |
| 20-Sep-24 4:39 PM View: | Heron Patrick J Director | Mirum Pharmaceuticals, Inc. (MIRM) | 18-Sep-24 | Purchase | 115 | $37.40 | $4,301.00 | < 1% 3.73M to 3.73M | |
| 12-Sep-24 4:18 PM View: | Bjerkholt Eric Chief Financial Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 11-Sep-24 | Option Exercise | 18,334 | -- | -- | 127% 14.47K to 32.8K | |
| 24-Jul-24 5:32 PM View: | Peetz Christopher CHIEF EXECUTIVE OFFICER Director | Mirum Pharmaceuticals, Inc. (MIRM) | 23-Jul-24 | Option Exercise | 34,013 | $2.94 | $99,862.20 | 11% 301.34K to 335.35K | |
| 03-Jul-24 6:19 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Jul-24 | Option Sale | 375 | $34.00 | $12,750.00 | (13%) 2.8K to 2.43K | |
| 03-Jul-24 6:19 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 01-Jul-24 | Option Exercise | 1,042 | -- | -- | 59% 1.76K to 2.8K | |
| 25-Jun-24 5:15 PM View: | Vig Pamela CHIEF SCIENTIFIC OFFICER | Mirum Pharmaceuticals, Inc. (MIRM) | 24-Jun-24 | Option Exercise | 30,559 | $2.94 | $89,721.20 | 30% 102.41K to 132.97K | |
| 25-Jun-24 5:15 PM View: | Vig Pamela CHIEF SCIENTIFIC OFFICER | Mirum Pharmaceuticals, Inc. (MIRM) | 24-Jun-24 | Planned Option Sale | 30,559 | $34.00 | $1,039,010.00 | (23%) 132.97K to 102.41K | |
| 07-Jun-24 6:20 PM View: | Ramasastry Saira Director | Mirum Pharmaceuticals, Inc. (MIRM) | 05-Jun-24 | Option Sale | 5,000 | $25.68 | $128,400.00 | (100%) 5.0K to 0 | |
| 07-Jun-24 6:20 PM View: | Ramasastry Saira Director | Mirum Pharmaceuticals, Inc. (MIRM) | 05-Jun-24 | Option Exercise | 5,000 | $14.12 | $70,600.00 | 100% 0 to 5.0K | |
| 16-May-24 4:30 PM View: | Bjerkholt Eric Chief Financial Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 10-May-24 | Grant | 470 | $21.05 | $9,891.62 | 3% 14.0K to 14.47K | |
| 16-May-24 4:30 PM View: | Peetz Christopher CHIEF EXECUTIVE OFFICER Director | Mirum Pharmaceuticals, Inc. (MIRM) | 10-May-24 | Grant | 817 | $21.05 | $17,194.60 | < 1% 300.52K to 301.34K | |
| 16-May-24 4:30 PM View: | Vig Pamela CHIEF SCIENTIFIC OFFICER | Mirum Pharmaceuticals, Inc. (MIRM) | 10-May-24 | Grant | 94 | $21.05 | $1,978.32 | < 1% 102.31K to 102.41K | |
| 27-Mar-24 8:47 PM View: | Bjerkholt Eric Chief Financial Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 27-Mar-24 | Purchase | 2,000 | $24.80 | $49,600.00 | 17% 12.0K to 14.0K | |
| 25-Mar-24 5:41 PM View: | Radovich Peter PRESIDENT AND COO | Mirum Pharmaceuticals, Inc. (MIRM) | 25-Mar-24 | Private Sale | 4,303 | $25.80 | $111,017.00 | (13%) 33.32K to 29.01K | |
| 18-Mar-24 5:34 PM View: | Bjerkholt Eric Chief Financial Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 18-Mar-24 | Purchase | 2,000 | $25.80 | $51,600.00 | 20% 10.0K to 12.0K | |
| 05-Feb-24 9:10 PM View: | Longpre Lara Chief Development Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Feb-24 | Private Sale | 847 | $26.19 | $22,184.50 | (< 1%) 105.25K to 104.41K | |
| 05-Feb-24 9:04 PM View: | Peetz Christopher CHIEF EXECUTIVE OFFICER Director | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Feb-24 | Private Sale | 6,013 | $26.19 | $157,491.00 | (2%) 311.69K to 305.68K | |
| 05-Feb-24 9:12 PM View: | Vig Pamela CHIEF SCIENTIFIC OFFICER | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Feb-24 | Private Sale | 1,214 | $26.19 | $31,796.80 | (1%) 104.91K to 103.69K | |
| 02-Feb-24 9:28 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Feb-24 | Option Sale | 735 | $26.19 | $19,251.00 | (29%) 2.49K to 1.76K | |
| 05-Feb-24 9:05 PM View: | Radovich Peter PRESIDENT AND COO | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Feb-24 | Private Sale | 1,790 | $26.19 | $46,883.10 | (5%) 36.48K to 34.7K | |
| 02-Feb-24 9:28 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 31-Jan-24 | Option Exercise | 1,772 | -- | -- | 245% 0.72K to 2.49K | |
| 09-Jan-24 8:25 PM View: | Longpre Lara Chief Development Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Jan-24 | Private Sale | 1,019 | $28.03 | $28,567.70 | (< 1%) 106.27K to 105.25K | |
| 09-Jan-24 8:12 PM View: | Peetz Christopher CHIEF EXECUTIVE OFFICER Director | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Jan-24 | Private Sale | 5,209 | $28.03 | $146,033.00 | (2%) 316.9K to 311.69K | |
| 09-Jan-24 8:09 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Jan-24 | Option Sale | 528 | $28.04 | $14,802.50 | (42%) 1.25K to 0.72K | |
| 09-Jan-24 8:21 PM View: | Vig Pamela CHIEF SCIENTIFIC OFFICER | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Jan-24 | Private Sale | 1,408 | $28.03 | $39,472.30 | (1%) 106.31K to 104.91K | |
| 09-Jan-24 8:28 PM View: | Radovich Peter PRESIDENT AND COO | Mirum Pharmaceuticals, Inc. (MIRM) | 08-Jan-24 | Private Sale | 1,408 | $28.03 | $39,472.60 | (4%) 37.89K to 36.48K | |
| 09-Jan-24 8:09 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 06-Jan-24 | Option Exercise | 1,250 | -- | -- | 100% 0 to 1.25K | |
| 06-Dec-23 5:16 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 05-Dec-23 | Option Exercise | 2,500 | $2.94 | $7,350.00 | 100% 0 to 2.5K | |
| 06-Dec-23 5:16 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 05-Dec-23 | Option Sale | 2,500 | $32.40 | $81,000.00 | (100%) 2.5K to 0 | |
| 15-Nov-23 8:11 PM View: | Radovich Peter PRESIDENT AND COO | Mirum Pharmaceuticals, Inc. (MIRM) | 10-Nov-23 | Grant | 218 | $22.29 | $4,858.57 | < 1% 37.67K to 37.89K | |
| 15-Nov-23 8:14 PM View: | Vig Pamela CHIEF SCIENTIFIC OFFICER | Mirum Pharmaceuticals, Inc. (MIRM) | 10-Nov-23 | Grant | 527 | $22.29 | $11,745.20 | < 1% 105.79K to 106.31K | |
| 15-Nov-23 8:13 PM View: | Longpre Lara Chief Development Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 10-Nov-23 | Grant | 434 | $22.29 | $9,672.56 | < 1% 105.84K to 106.27K | |
| 14-Nov-23 10:00 PM View: | Heron Patrick J Director | Mirum Pharmaceuticals, Inc. (MIRM) | 09-Nov-23 | Purchase | 2,910 | $28.30 | $82,353.00 | < 1% 3.73M to 3.73M | |
| 14-Sep-23 7:33 PM View: | Grey Michael G Director | Mirum Pharmaceuticals, Inc. (MIRM) | 14-Sep-23 | Option Exercise | 14,216 | $2.94 | $41,738.20 | 4% 382.95K to 397.16K | |
| 14-Sep-23 7:33 PM View: | Grey Michael G Director | Mirum Pharmaceuticals, Inc. (MIRM) | 14-Sep-23 | Planned Option Sale | 14,216 | $32.00 | $454,912.00 | (4%) 397.16K to 382.95K | |
| 14-Sep-23 7:33 PM View: | Grey Michael G Director | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Sep-23 | Option Exercise | 392 | $2.94 | $1,150.91 | < 1% 382.95K to 383.34K | |
| 15-Sep-23 4:56 PM View: | Heron Patrick J Director | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Sep-23 | Purchase | 2,625 | $31.02 | $81,424.90 | < 1% 3.72M to 3.73M | |
| 14-Sep-23 7:33 PM View: | Grey Michael G Director | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Sep-23 | Planned Option Sale | 392 | $32.00 | $12,544.00 | (< 1%) 383.34K to 382.95K | |
| 13-Sep-23 4:39 PM View: | Heron Patrick J Director | Mirum Pharmaceuticals, Inc. (MIRM) | 12-Sep-23 | Purchase | 3,750 | $30.60 | $114,764.00 | < 1% 3.72M to 3.72M | |
| 12-Sep-23 6:23 PM View: | Bjerkholt Eric Chief Financial Officer | Mirum Pharmaceuticals, Inc. (MIRM) | 11-Sep-23 | Purchase | 10,000 | $29.65 | $296,492.00 | 100% 0 to 10.0K | |
| 13-Sep-23 4:39 PM View: | Heron Patrick J Director | Mirum Pharmaceuticals, Inc. (MIRM) | 11-Sep-23 | Purchase | 4,687 | $30.30 | $142,027.00 | < 1% 3.71M to 3.72M | |
| 05-Sep-23 12:51 PM View: | Heron Patrick J Director 10% Owner | Mirum Pharmaceuticals, Inc. (MIRM) | 31-Aug-23 | Purchase | 147,991 | $26.25 | $3,884,760.00 | 4% 3.57M to 3.71M | |
| 28-Aug-23 4:30 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 25-Aug-23 | Private Sale | 3,459 | $26.23 | $90,743.10 | (100%) 3.46K to 0 | |
| 05-Jul-23 10:00 PM View: | Howe Jolanda SVP, Global Controller | Mirum Pharmaceuticals, Inc. (MIRM) | 03-Jul-23 | Option Sale | 915 | $25.65 | $23,466.60 | (21%) 4.37K to 3.46K |
